TAIPEI, Taiwan, May 01, 2025 (GLOBE NEWSWIRE) — OBI Pharma, Inc. (“OBI”), a clinical stage oncology company（4174.TWO), today announced that the U.S. Food and Drug Administration ... solid tumors. This ...

Therefore, TI and DI exhibit a non-linear influence on MFP, suggesting an inverted U-shaped link between TI, DI, and MFP over the long term. Thus, TI and DI contribute to a resource curse up to ...

Let him tell you what he loves. Trending on Billboard When we meet Carner for his first Billboard U.K. cover shoot — and first interview about hopefully ! — he brings that lightness with him.

The company states: “Verastem (VSTM) announced the U.S. Food and Drug Administration has cleared the Investigational New Drug application of VS-7375, an oral KRAS G12D inhibitor for clinical ...

The IND clearance is an important milestone for the company, and we are laser-focused on driving ETX-636 through clinical development," said Shengfang Jin, PhD, CEO and Co-Founder of ENSEM.

Grade 3) and ineligible for transplant will be enrolled across multiple U.S. centers ... OrganOx ELC system in these patients. "The FDA's clearance of EGEN-5784 in combination with the OrganOx ...

Phil speaks with Dr. Adrian Cohen, Founder of Headsafe, as the company receives final FDA clearance for its Nurochek-Pro device ... Headsafe will soon launch Nurochek-Pro in the U.S., led by ...

today announced receipt of U.S. Food and Drug Administration (FDA) clearance for the Investigational New Drug (IND) application for ALX2004, the company’s potential best- and first-in-class ...